CVS Health Reports Strong First Quarter 2026 Results and Upgrades Full-Year Guidance
CVS Health Corporation (NYSE: CVS) has released its operating results for the first quarter of 2026, showcasing impressive financial performance and a robust outlook for the remainder of the year. The company has increased its full-year guidance, responding to strong execution across its various business segments.
1. Key Financial Highlights
For the three months ending March 31, 2026, CVS Health reported:
- Total Revenues: $100.4 billion, marking a 6.2% increase from $94.6 billion in the same period last year.
- Diluted Earnings Per Share (EPS): $2.30, a significant rise from $1.41 in Q1 2025.
- Adjusted EPS: $2.57, up from $2.25 year-over-year.
- Operating Income: $4.68 billion, a notable increase of 38.7% compared to $3.37 billion in Q1 2025.
- Net Income: $2.96 billion, reflecting a $1.175 billion increase from $1.78 billion in the prior year.
The surge in earnings can be attributed to improved operating income within the Health Care Benefits segment, coupled with the absence of significant prior-year charges related to litigation and asset divestitures.
2. Enhanced Full-Year Guidance
CVS Health has raised its full-year 2026 guidance for GAAP diluted EPS to a range of $6.24 to $6.44 and adjusted EPS to between $7.30 and $7.50. The company anticipates total revenues will reach at least $405.0 billion. This optimistic outlook is driven by strong performance in the Health Care Benefits and Pharmacy & Consumer Wellness segments, even as the company remains cautious about ongoing cost trends and potential macroeconomic headwinds.
3. Segment Performance
Health Care Benefits Segment
The Health Care Benefits segment reported total revenues of $35.97 billion, up 3.3% from the previous year. Adjusted operating income surged by 52.6%, driven by improved performance in the Government business and the absence of a previously recorded premium deficiency reserve.
- Medical Benefit Ratio (MBR): Improved to 84.6% from 87.3% year-over-year.
- Medical Membership: Declined to 26.0 million, down by approximately 600 thousand members from the end of 2025, due to the company's exit from the individual exchange business.
Health Services Segment
This segment, which provides pharmacy benefit management and health care services, saw total revenues rise by 11.0% to $48.24 billion. However, adjusted operating income decreased by 7.1%, impacted by ongoing pharmacy client price improvements.
- Pharmacy Claims Processed: Remained stable, with a slight increase to 464.7 million claims.
Pharmacy & Consumer Wellness Segment
The Pharmacy & Consumer Wellness segment reported revenues of $31.99 billion, showing minimal growth from the previous year. Adjusted operating income decreased by 8.8% due to pharmacy reimbursement pressures and other factors.
- Prescriptions Filled: Increased by 3.6%, attributed to higher volumes from Rite Aid asset acquisitions and greater utilization.
4. Operational Updates
CVS Health has made significant strides in operational efficiency and service delivery:
- The company announced the launch of Health100, a health technology services subsidiary leveraging Google Cloud's AI technologies to enhance consumer engagement in health care.
- Aetna has made considerable progress in prior authorization reform, achieving industry-leading benchmarks in processing speed and efficiency.
- CVS Pharmacy continues to expand community access to care, including the introduction of small pharmacy locations designed to meet local health needs.
5. Conclusion
David Joyner, Chairman and CEO of CVS Health, emphasized the company's commitment to providing accessible health care solutions. He stated, "CVS Health continues to provide what people want most from health care: a connected, convenient, cost-effective engagement experience across our unique collection of businesses."
With strong first-quarter results and an optimistic outlook for 2026, CVS Health is well-positioned to navigate the complexities of the health care landscape, while continuing to build trust and deliver value to its vast customer base.
The company will discuss these results further in a conference call scheduled for 8:00 a.m. (Eastern Time) today, which will be available for streaming on its Investor Relations website.
